69 related articles for article (PubMed ID: 31289583)
1. The prevalence, associated factors for bone metastases development and prognosis in newly diagnosed ovarian cancer: a large population based real-world study.
Zhang C; Guo X; Peltzer K; Ma W; Qi L; Zhang Y; Han X; Baklaushev VP; Yao Y; Wang G; Chekhonin VP; Wang X; Ma Y
J Cancer; 2019; 10(14):3133-3139. PubMed ID: 31289583
[No Abstract] [Full Text] [Related]
2. Lung and bone metastases patterns in limb osteosarcoma: Surgical treatment of primary site improves overall survival.
Liu B; Tang L; Peng N; Wang L
Medicine (Baltimore); 2023 Oct; 102(42):e35671. PubMed ID: 37861481
[TBL] [Abstract][Full Text] [Related]
3. Brain and heart-specific death in cancer patients: Population-based study.
Safi M; Al-Nusaif M; Trapani D; Mashrah MA; Kanesvaran R; Alzandani A; Al-Azab M; Mazher SA; Al-Danakh A; Liu J
Cancer Med; 2021 Sep; 10(17):5739-5747. PubMed ID: 34374226
[TBL] [Abstract][Full Text] [Related]
4. Bone metastases among newly diagnosed cancer patients: a population-based study.
Chen F; He B; Wang Y
Postgrad Med J; 2024 Mar; ():. PubMed ID: 38497290
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of bone metastasis and the development of bone metastatic prognostic classification system: a pan-cancer population study.
Hu Z; Yang S; Xu Z; Zhang X; Wang H; Fan G; Liao X
Aging (Albany NY); 2023 Nov; 15(22):13134-13149. PubMed ID: 37983179
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for bone metastases at presentation in solid tumors.
Knapp BJ; Cittolin-Santos GF; Flanagan ME; Grandhi N; Gao F; Samson PP; Govindan R; Morgensztern D
Front Oncol; 2024; 14():1392667. PubMed ID: 38800383
[TBL] [Abstract][Full Text] [Related]
7. PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancer.
Horackova K; Vocka M; Lopatova S; Zemankova P; Kleibl Z; Soukupova J
Cancer Biomark; 2024 Mar; ():. PubMed ID: 38607753
[TBL] [Abstract][Full Text] [Related]
8. Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases: An NCDB Time-to-event Cohort.
Alexopoulos G; Zhang J; Karampelas I; Patel M; Mercier P
Am J Clin Oncol; 2023 Nov; 46(11):475-485. PubMed ID: 37561070
[TBL] [Abstract][Full Text] [Related]
9. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and prognostic predictors for Cervical Cancer patients with lung metastasis.
Chen X; Chen L; Zhu H; Tao J
J Cancer; 2020; 11(20):5880-5889. PubMed ID: 32922530
[No Abstract] [Full Text] [Related]
11. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
12. The Nomogram for Early Death in Patients with Bone and Soft Tissue Tumors.
Xu Y; Xu G; Wu H; Lin F; Mao M; Baklaushev VP; Chekhonin VP; Peltzer K; Wang J; Wang G; Wang X; Zhang C
J Cancer; 2020; 11(18):5359-5370. PubMed ID: 32742482
[No Abstract] [Full Text] [Related]
13. Racial disparities in bone metastasis patterns and targeted screening and treatment strategies in newly diagnosed lung cancer patients.
Xu G; Cui P; Zhang C; Lin F; Xu Y; Guo X; Cai J; Baklaushev VP; Peltzer K; Chekhonin VP; Wang X; Wang G
Ethn Health; 2022 Feb; 27(2):329-342. PubMed ID: 32223328
[No Abstract] [Full Text] [Related]
14. The Prevalence, Associated Factors for Lung Metastases Development and Prognosis in Ovarian Serous Cancer Based on SEER Database.
Cao C; Yang X
Technol Cancer Res Treat; 2020; 19():1533033820983801. PubMed ID: 33356997
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study.
Xi S; Li Z; Guo Q; Lin W; Liang X; Ma L
J Cancer; 2020; 11(15):4625-4640. PubMed ID: 32489480
[No Abstract] [Full Text] [Related]
16. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and risk factors associated with lung metastases in newly diagnosed epithelial ovarian cancer with a look on prognosis after diagnosis: a population-based cohort study of the SEER database.
Xu J; Hussain I; Wang L; Deng K; Zhao L; Zhou K; Zhang L; Xu Z; Li K
Arch Gynecol Obstet; 2021 Oct; 304(4):1007-1020. PubMed ID: 33635405
[TBL] [Abstract][Full Text] [Related]
18. The Prevalence and associated Factors for Liver Metastases, Development and Prognosis in newly diagnosed Epithelial Ovarian Cancer: A large Population-Based Study from the SEER Database.
Hussain I; Xu J; Deng K; Noor-Ul-Amin ; Wang C; Huang Y; Li S; Li K
J Cancer; 2020; 11(16):4861-4869. PubMed ID: 32626533
[No Abstract] [Full Text] [Related]
19. The Importance of Marital Status in the Morbidity and Prognosis of Lung Metastasis in Newly Diagnosed Ovarian Cancer.
Qian L; Chen Y; Peng M; Xia Y; Zhou T; Hong J; Ding S
J Cancer; 2023; 14(6):1024-1038. PubMed ID: 37151400
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
